New policy addresses management liability needs unique to life sciences, biotech, and pharmaceutical firms and is specifically designed for the R&D ecosystem.
Reinsurer forecasts near-normal typhoon activity in region and above-average hurricane activity in the Atlantic, but warns of greater than usual differences among researchers’ predictions for 2025.
The 21st Singapore International Reinsurance Conference will explore key industry risks, including geopolitical and economic shifts, climate change, and new technologies.
Approval represents a key milestone in the deal, with the competition watchdog concluding the market will remain competitive following the acquisition.
